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Mycoplasma arthritidis generates a soluble, non-dialysable, polyclonal mitogen which is ac-
tive for murine and human T lymphocytes in the presence of an adherent, radio-resistant, la-
bearing accessory cell population. Genetic analysis has established that the I-E sub-region of
the murine H2 gene complexcontrols responses to themitogen and that this control is exercised
at the level of the Ia-bearing accessory cell. Lymphocyte proliferation, induction of cytotoxic
lymphocytes, and interferon induction are all under Irgenecontrol and appear to be dependent
upon binding of the mitogen to a specific Ia antigen present on a subset of splenic cells. This
mycoplasma mitogen provides a new model system to define the mechanisms of Ir gene control
of lymphocyte activation.
INTRODUCTION
Microbial mitogens are receiving increasing attention as possible contributors to
the pathogenesis of disease and to altered immune responses. Many mycoplasmas
are known to exert mitogenic effects on normal unsensitized lymphocytes from a
variety of hosts [1,2,3]. Whereas it is the murine B-cell subpopulation which
responds to M. pneumoniae, A. laidlawii, and M. neurolyticum [4,5,6], both B cells
and T cells respond to M. pulmonis [7]. Human T cells were also reported to be
stimulated by A. laidlawii [5] and M. pneumoniae [8]. Emphasis in our laboratories
has been on lymphocyte interactions with M. arthritidis. Since this organism is a po-
tent arthritogenic agent of mice, rats, and rabbits [9], detailed study of its
lymphocyte-activating properties may provide clues as to the mechanisms of
pathogenesis of the diseases induced.
In this review I will summarize current knowledge concerning the T-lymphocyte-
activating component ofM. arthritidis, the cellular collaborations required, and the
genetic control of T-lymphocyte activation. In addition, other properties of the
mitogen, including macrophage activation and ability to induce interferon, will also
bedescribed. Detailed methodology can be found in the cited references. Thegenetic
studies are summarized in Table 1.
RESULTS
Cellular Requirementsfor T-Cell Activation ofM. arthritidis
The first evidence that M. arthritidis might produce a T-cell activator was in our
observation that viable organisms induced splenic cells to become cytotoxic for
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syngeneic and allogeneic fibroblast targets [10]. Furthermore, cytotoxic activity was
abolished by removing T cells by treatment with anti-Thy 1 antibody and comple-
ment [11]. Interestingly, non-viable washed M. arthritidis preparations were without
significant T-cell activating properties. We also demonstrated that viable M. ar-
thritidis was mitogenic for murine splenic cells, providing that multiplication of the
organisms was controlled by antibiotics or that excess arginine was incorporated into
culture media [1]. Lymphocyte proliferation was abolished by elimination of the T
cells. Removal of adherent splenic cells by passage over nylon columns also abol-
ished reactivity, suggesting a role for the macrophage or dendritic cell. We finally
demonstrated that purified T cells were only activated by MAS in the presence of an
adherent, Ta antigen-bearing, radio-resistant, accessory cell population [12].
Further study on the mitogenic moiety of M. arthritidis showed that the active
component was present in supernatants from M. arthritidis broth cultures (MAS).
Mitogenic activity was shown to be non-sedimentable for 15 hours at 110,000 g,
non-dialysable, partially labile to 56°C for one hour, and inactivated by sepharose-
bound protease [12]. The polyclonal nature of the T-cell mitogen has now been
established [Gurish, Cole, Daynes: J Immunol, in press]. These results are impor-
tant since the existence of a soluble mitogen indicates that mycoplasmas can activate
lymphoid cells without the necessity for cell-cell interactions. The mitogen was also
active for rat and human lymphocytes but not for rabbit, guinea pig, ovine, or
bovine lymphocytes [13]. Human T lymphocytes also required an accessory cell
population [14].
Ir Gene Control ofLymphocyte Activation
During this time, experiments were also being conducted to determine whether
lymphocytes from different strains of mice reacted differently to the lymphocyte-
activating properties of M. arthritidis. Using both proliferation and cytotoxicity
assays with viable M. arthritidis and M. arthritidis supernatants (MAS), we
established that lymphocytes from inbred mice of the k haplotype, i.e., CBA and
C3H, and of the d haplotype, i.e., Balb/c, are responsive to M. arthritidis, whereas
lymphocytes from b haplotype mice, i.e., C57BL/6 or C57BL/10, are non-
responsive [15]. Furthermore, lymphocyte reactivity was shown to be dependent
upon the haplotype expressed at the H2 gene complex. This conclusion was reached
since congenic mouse strains, which differed from the parental strain only in the
haplotype expressed at H2, always responded according to the haplotype at H2, and
not the background haplotype. By using recombinant mice which express different
haplotypes at different regions of the H2 complex, we identified the I-E sub-region
as responsible for the genetic control of activation [15,16] (Table 1).
The demonstration of I-E region control for the mycoplasma mitogen appears to
be unique. Although differences in the degree of responsiveness of lymphocytes
from various mouse strains to the T-cell mitogens concanavalin A (Con-A) and
phytohemagglutinin (PHA) have been identified, the genetic control of these dif-
ferences appears to lie outside the H2 gene complex [17].
The availability of responder and non-responder mouse strains provided an op-
portunity to determine whether the genetic control of lymphocyte activation was
mediated at the level of the T cell or the accessory cell. We showed that purified T
cells from Fl hybrids between responder (C3H) and non-responder (C57BL/6) mice
were activated by MAS in the presence of accessory cells from the hybrid or the C3H
mice but were not stimulated in the presence of accessory cells from C57BL/6 mice.
607In contrast, T-cell responses to Con-A were supported by accessory cells from all
strains of mice. Thus, the accessory cell appears to be responsible for the genetic
control of lymphocyte reactivity to MAS [12].
Mitogen Binding to Lymphocyte Surfaces
The next phase of the work was designed to study the interaction of the mitogen
with splenic cells. A key question was to determine whether the mitogen bound only
toresponsive lymphocytes or whether, as for theplant mitogens, it bound to all lym-
phoid cells. A 1:250 dilution of MAS was absorbed twice at 37°C for one hour with
5 x 10' splenic lymphoid cells from CBA or C57BL/10 mice. Cells were removed
by centrifugation and the supernatants assayed at a 1:5 dilution for lymphocyte pro-
liferation, using fresh CBA splenic cells. Whereas unabsorbed MAS induced marked
proliferation oflymphocytes, treatment with responsive CBA spleen cells resulted in
a virtual loss of mitogenic activity. In contrast, MAS absorbed with non-responsive
C57BL/10 splenic cells retained full activity [18]. Lesser concentrations of respon-
sive lymphocytes only partially removed the activity.
Similar absorption experiments using spleen cells from congenic and appropriate
background mice established that the ability to absorb the mitogen was dependent
upon the H2 gene complex. By using recombinant mice, we further demonstrated
that mitogen binding was dependent upon the haplotype expressed at the I-E sub-
region of the murine H2 gene complex and appeared to associate with the presence
of the Ia7 serological specificity. To confirm the latter association, we compared
binding of the mitogen to splenic cells from two strains of mice (A.TFR5 and
A.TFR4) which differed in Ia antigen expression only in the presence or absence of
Ia7, respectively. Only those lymphocytes whichgenotypically express Ia7 bound the
mitogen [18]. However, binding to A.TFR5 splenic cells was much less than that
seen with either CBA, C3H, or Balb/c cells [18]. The lesser binding may correlate
with the poor phenotypic expression of Ia7 on A.TFR5 cells [19]. Most I-E region-
coded molecules consist of an a and a ,Bchain. Since the 1a7 specificity when present
is borne on the a chain ofthe molecule and since the achain is absent from A.TFR5
mice [20], our results imply that mitogen binding is associated with the presence of
the a chain of the I-E molecule.
Thus, there appears to be complete correlation between the ability of MAS to ac-
tivate lymphocytes and to bind the splenic cells (Table 1). An attractive hypothesis
for these findings is that an Ir region product, i.e., an Ia antigen, acts as the receptor
site for the mitogen. A number ofexperiments were conducted to address this issue.
First, we compared the ability of the mitogen to bind to various lymphocyte sub-
populations of CBA mice. Splenic cells depleted of T cells by treatment with anti-
Thy 1 antiserum and complement were just as effective in mitogen removal from
MAS as were spleen cells treated with complement alone. Thymocytes were ineffec-
tive in removing themitogen, confirming that the T cell is not the binding cell. How-
ever, treatment of splenic cells with syngeneic anti-Ia antiserum (ATH anti-ATL)
and complement markedly reduced their binding capacity. Other experiments have
shown that glass-adherent cells are also capable ofbinding the mitogen. Further evi-
dence for the role of Ia antigens comes from studies in which we demonstrated that
syngeneic anti-Ia antiserum, in the absence ofcomplement, blocked proliferative re-
sponses to MAS but was minimally effective toward responses to PHA and Con-A
[18]. The combined data strongly suggest that the mitogen binds to Ia-bearing cells
which are then able in some way to present it to the T cell. The future use ofisolated
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Ta antigens and monoclonal antibodies directed against specific I-E region determi-
nants are now required to identify definitively the precise binding site on the I-E
coded molecule.
Macrophage Activation by M. arthritidis
Since the Ia-bearing adherent cells, i.e., macrophages or dendritic cells, play a key
role in T-lymphocyte responses to MAS, experiments were undertaken to determine
whether M. arthritidis exhibited other effects on macrophage functions. Evidence
that some mycoplasmas activate macrophages has been obtained by Hibbs [21] and
Taylor-Robinson et al. [22]. However, since peritoneal macrophages were used, the
activation seen might have been mediated by lymphokine activity, generated by ac-
tivation ofcontaminating lymphocytes. To avoid this problem, our studies were per-
formed using the J774.1 continuous macrophage line which originated from the
responder Balb/c (H2d) mouse strain.
First, we determined whether either viable M. arthritidis or MAS induced mor-
phological changes. Whereas untreated macrophages, treated with uninoculated
mycoplasma broth, exhibited a uniform smooth appearance, those exposed for 24
hours to viable M. arthritidis or MAS showed changes characteristic of those
induced by BCG cell walls. Thus, the macrophages developed enhanced spreading,
pseudopod-like extensions of the membrane and numerous endocytic vesicles and
phagosomes [23]. Additional studies showed that macrophages treated with viable
M. arthritidis or MAS and extensively washed exhibited similar changes in function
to those induced with BCG cell walls, i.e., enhanced listericidal activity, acquisition
of tumoricidal properties, enhanced production of acid phosphatase, and increased
uptake of '4C glucosamine [23]. It remains to be determined whether the
macrophage-activating component in MAS is in fact the mitogenic moiety. Mitogen
purification studies now under way will eventually answer this question. The
mechanisms of macrophage activation and the role of mycoplasmas to alter con-
tinuous line macrophage functions poses yet another potential pitfall for the cell
biologist unaware of the presence of these contaminants.
Interferon Induction by M. arthritidis
Previous studies from our laboratories indicated that mycoplasmas induced in-
terferon in vivo in mice and in sheep and human lymphocyte cultures [24,25,26].
These and recent studies by other investigators [27] suggested that the interferon
produced was a interferon. Alpha interferon is characteristically induced by viruses
and B-cell mitogens, whereas T-cell mitogens characteristically induce immune or -y
interferon. Thus our new finding that M. arthritidis produces a T-cell mitogen is
paradoxical in view of the ability of this organism to induce a interferon in mice.
Preliminary studies presented at this conference [28] and now in press [Cole,
Thorpe: J Immunol, 1983] indicate that MAS is in fact an inducer of human y in-
terferon. We also investigated this issue using CBA mouse lymphocyte cultures with
MAS. Interferon was detected after 24 hours and peaked after three to four days.
The anti-viral substance was subjected to the usual criteria for acceptance as an in-
terferon and, furthermore, was shown to be pH labile and neutralized by anti-'y in-
terferon. antibody but not by anti-a interferon antibody. By comparing the in-
terferon response of lymphocytes from various inbred, congenic, and recombinant
mice we further demonstrated a complete correlation between the ability of MAS to
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induce interferon and its ability to induce lymphocyte proliferation. Thus the induc-
tion of -y interferon by MAS is also under Ir gene control (Table 1).
DISCUSSION
There are many important implications which arise from these studies. First, the
M. arthritidis mitogen represents a new tool to examine the mechanisms of Ir gene
control oflymphocyte activation. la antigens, the proposed products of Ir genes, are
considered to play a pivotal role as recognition markers for the cell collaborations
necessary for generation of humoral and cellular immune responses. Our system
suggests that Ia antigens might serve as receptor sites for T-lymphocyte-activating
substances.
Second, since responder and non-responder mouse strains are available, we have
an ideal model to examine the role of mitogen-induced lymphocyte activation in
various disease processes. The chronic inflammatory disease induced by many
mycoplasmas is highly suggestive of a massive stimulation of cells of the immune
system. In the case of M. pulmonis, evidence has been obtained that mitogen-
containing extracts can induce pneumonic lesions [29].
Third, these studies have also shown that -y interferon induced by a microbial
mitogen can also be under Ir gene control. One implication of this new finding is
that this reaction may represent a potentially potent genetic control mechanism for
susceptibility to infectious disease. Thus, 'y interferon, which is known to act
synergistically with a interferon [30], is becoming recognized as a powerful
modulator of immune response and host defenses; M. arthritidis and some bacteria
do in fact induce both a and 'y interferons.
It remains to be determined whether the genetic control of the T-cell mitogen of
M. arthritidis represents a unique system or whether other mycoplasmas or bacteria
will eventually be shown to possess similarly acting mitogens. Studies by Stanbridge
et al. [311 using whole M. hyorhinis organisms indicated differences in the degree of
proliferation oflymphocytes from different recombinant mouse strains. Differences
in the degree ofproliferation ofLEW and F344 rat lymphocytes toM. pulmonisand
other mitogens have also been reported at this conference [32]. These studies should
be continued and the genetic control mechanisms identified.
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